Acute Myeloid Leukemia Stocks List

Recent Signals

Date Stock Signal Type
2021-05-14 AIKI MACD Bullish Signal Line Cross Bullish
2021-05-14 AIKI NR7 Range Contraction
2021-05-14 APRE Bullish Engulfing Bullish
2021-05-14 APRE Bollinger Band Squeeze Range Contraction
2021-05-14 APRE Stochastic Buy Signal Bullish
2021-05-14 ARAV Stochastic Buy Signal Bullish
2021-05-14 ARAV Slingshot Bearish Bearish Swing Setup
2021-05-14 ARGX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 ATNM NR7 Range Contraction
2021-05-14 ATNM New Downtrend Bearish
2021-05-14 BEAM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 BLRX Narrow Range Bar Range Contraction
2021-05-14 BLRX NR7 Range Contraction
2021-05-14 BLRX 1,2,3 Pullback Bullish Bullish Swing Setup
2021-05-14 CGEM New 52 Week Closing Low Bearish
2021-05-14 CLLS Slingshot Bearish Bearish Swing Setup
2021-05-14 CLLS Bullish Engulfing Bullish
2021-05-14 CRDF 20 DMA Resistance Bearish
2021-05-14 CTIC NR7 Range Contraction
2021-05-14 GLYC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 GLYC Fell Below 20 DMA Bearish
2021-05-14 GMAB Crossed Above 200 DMA Bullish
2021-05-14 GMAB Bollinger Band Squeeze Range Contraction
2021-05-14 KRON 20 DMA Support Bullish
2021-05-14 KRON 50 DMA Resistance Bearish
2021-05-14 KRON Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 MBRX Bollinger Band Squeeze Range Contraction
2021-05-14 MBRX MACD Bearish Signal Line Cross Bearish
2021-05-14 MRUS Crossed Above 20 DMA Bullish
2021-05-14 MRUS NR7 Range Contraction
2021-05-14 MRUS 50 DMA Resistance Bearish
2021-05-14 NEXI Jack-in-the-Box Bearish Bearish Swing Setup
2021-05-14 NEXI Narrow Range Bar Range Contraction
2021-05-14 SLS Bollinger Band Squeeze Range Contraction
2021-05-14 SLS Pocket Pivot Bullish Swing Setup
2021-05-14 SLS Crossed Above 20 DMA Bullish
2021-05-14 SLS Doji - Bearish? Reversal
2021-05-14 SYRS MACD Bullish Signal Line Cross Bullish
2021-05-14 SYRS 1,2,3 Retracement Bearish Bearish Swing Setup
2021-05-14 SYRS NR7 Range Contraction
2021-05-14 SYRS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 TRIL Bollinger Band Squeeze Range Contraction
2021-05-14 TRIL Lower Bollinger Band Walk Weakness
2021-05-14 TRIL Stochastic Reached Oversold Weakness
2021-05-14 VOR New Downtrend Bearish
2021-05-14 VOR New 52 Week Low Weakness
2021-05-14 VOR New 52 Week Closing Low Bearish
2021-05-14 VOR Lower Bollinger Band Walk Weakness
2021-05-14 XBIO Lower Bollinger Band Walk Weakness
2021-05-14 XBIO Jack-in-the-Box Bearish Bearish Swing Setup
2021-05-14 XBIO New Downtrend Bearish

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cells. Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. Occasionally spread may occur to the brain, skin, or gums. As an acute leukemia, AML progresses rapidly and is typically fatal within weeks or months if left untreated.Risk factors include smoking, previous chemotherapy or radiation therapy, myelodysplastic syndrome, and exposure to the chemical benzene. The underlying mechanism involves replacement of normal bone marrow with leukemia cells, which results in a drop in red blood cells, platelets, and normal white blood cells. Diagnosis is generally based on bone marrow aspiration and specific blood tests. AML has several subtypes; for which treatments and outcomes may vary.AML, typically is initially treated with chemotherapy aimed at inducing remission. People may then go on to receive additional chemotherapy, radiation therapy, or a stem cell transplant. The specific genetic mutations present within the cancer cells may guide therapy, as well as determine how long that person is likely to survive. Arsenic trioxide may be tried in cases that have recurred following usual treatments.AML affected about one million people globally in 2015 and resulted in 147,000 deaths. It most commonly occurs in older adults. Males are affected more often than females. AML is curable in about 35% of people under 60 years old and 10% over 60 years old. Older people who are not healthy enough to receive intensive chemotherapy have a typical survival of 5–10 months. It accounts for roughly 1.8% of cancer deaths in the United States.

More about Acute Myeloid Leukemia
Browse All Tags